Hyperpolarization-activated cyclic nucleotide-gated channel 1–2 heteromer (HCN1/2)

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are essential components of the mammalian nervous system, where they generate the pacemaker current known as Ih (Biel et al., 2009). While four distinct isoforms exist, HCN1 and HCN2 frequently co-assemble to form heteromeric channels, particularly within the thalamus, hippocampus, and peripheral sensory neurons (Much et al., 2003). These heteromers exhibit unique biophysical properties, such as activation kinetics and cAMP sensitivity, that are intermediate between their respective homomeric counterparts. In the central nervous system, HCN1–HCN2 heteromers regulate neuronal rhythmicity and synaptic integration, while in the peripheral nervous system, they are critical for modulating the excitability of dorsal root ganglion neurons (Emery et al., 2012). Dysregulation of these channels is strongly associated with pathological conditions including neuropathic pain and various forms of epilepsy, making them high-priority therapeutic targets. Current pharmacological agents like ivabradine target the pore of these channels to reduce hyperexcitability, though achieving selectivity for heteromers over homomers remains a significant challenge (Postea & Biel, 2011). Understanding the specific role of the HCN1–HCN2 complex is vital for developing targeted analgesics and anti-epileptic medications with fewer cardiac side effects.

Other names

HCN1-HCN2 heteromeric channelHCN1/2 complexIh channelPacemaker channelHyperpolarization-activated cation current channel

Direct blockade of the ion-conducting pore and modulation of the voltage-dependent activation threshold to reduce the hyperpolarization-activated cation current (Ih).